雌激素受体阴性/孕激素受体阳性乳腺癌存在吗？ - Suppr

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

作者信息

De Maeyer Leen, Van Limbergen Erik, De Nys Katelijne, Moerman Philippe, Pochet Nathalie, Hendrickx Wouter, Wildiers Hans, Paridaens Robert, Smeets Ann, Christiaens Marie-Rose, Vergote Ignace, Leunen Karin, Amant Frederic, Neven Patrick

出版信息

J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. doi: 10.1200/JCO.2007.14.8411.

DOI:10.1200/JCO.2007.14.8411

PMID:18182677

Abstract

摘要

相似文献

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. doi: 10.1200/JCO.2007.14.8411.

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17.

Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

J Clin Oncol. 2008 Jul 1;26(19):3286-8; author reply 3288. doi: 10.1200/JCO.2008.17.1116.

Triple-negative breast cancer: a short review.

Am J Clin Oncol. 2010 Dec;33(6):637-45. doi: 10.1097/COC.0b013e3181b8afcf.

E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma.

Ann Surg Oncol. 2010 Feb;17(2):564-71. doi: 10.1245/s10434-009-0767-z. Epub 2009 Oct 20.

Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem.

J Clin Oncol. 2004 Dec 1;22(23):4660-2. doi: 10.1200/JCO.2004.07.961. Epub 2004 Oct 25.

[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):128-31.

[Changing behavior of estrogen and progesterone receptors with metastasis or recurrence of breast cancer].

Gan To Kagaku Ryoho. 2006 Jul;33(7):925-9.

Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

Clin Cancer Res. 2008 Oct 15;14(20):6625-33. doi: 10.1158/1078-0432.CCR-08-0701.

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14.

引用本文的文献

Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer.

Transl Oncol. 2025 Jun;56:102387. doi: 10.1016/j.tranon.2025.102387. Epub 2025 Apr 14.

Breast acinic cell carcinoma with weak progesterone receptor expression: a case report and literature review.

Front Oncol. 2025 Feb 20;14:1497272. doi: 10.3389/fonc.2024.1497272. eCollection 2024.

Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ERPRHER2) breast cancer.

Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023.

Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.

Cancer Causes Control. 2024 Jun;35(6):921-933. doi: 10.1007/s10552-024-01856-6. Epub 2024 Feb 16.

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy.

Diagn Pathol. 2024 Jan 4;19(1):5. doi: 10.1186/s13000-023-01433-6.

Visualized machine learning models combined with propensity score matching analysis in single PR-positive breast cancer prognosis: a multicenter population-based study.

Am J Cancer Res. 2023 Jun 15;13(6):2234-2253. eCollection 2023.

Single progesterone receptor-positive phenotype has the similar clinicopathological features and outcome as triple-negative subtype in metastatic breast cancer.

Front Oncol. 2023 Feb 24;13:1029648. doi: 10.3389/fonc.2023.1029648. eCollection 2023.

An update on the pathological classification of breast cancer.

Histopathology. 2023 Jan;82(1):5-16. doi: 10.1111/his.14786.

CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.

Cancers (Basel). 2022 Nov 6;14(21):5453. doi: 10.3390/cancers14215453.

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.

Breast J. 2022 May 17;2022:9238804. doi: 10.1155/2022/9238804. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

作者信息

出版信息

J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. doi: 10.1200/JCO.2007.14.8411.

DOI:10.1200/JCO.2007.14.8411

PMID:18182677

Abstract

摘要

相似文献

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

J Clin Oncol. 2008 Jan 10;26(2):335-6; author reply 336-8. doi: 10.1200/JCO.2007.14.8411.

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17.

Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

J Clin Oncol. 2008 Jul 1;26(19):3286-8; author reply 3288. doi: 10.1200/JCO.2008.17.1116.

Triple-negative breast cancer: a short review.

Am J Clin Oncol. 2010 Dec;33(6):637-45. doi: 10.1097/COC.0b013e3181b8afcf.

E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma.

Ann Surg Oncol. 2010 Feb;17(2):564-71. doi: 10.1245/s10434-009-0767-z. Epub 2009 Oct 20.

Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problem.

J Clin Oncol. 2004 Dec 1;22(23):4660-2. doi: 10.1200/JCO.2004.07.961. Epub 2004 Oct 25.

[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):128-31.

[Changing behavior of estrogen and progesterone receptors with metastasis or recurrence of breast cancer].

Gan To Kagaku Ryoho. 2006 Jul;33(7):925-9.

Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

Clin Cancer Res. 2008 Oct 15;14(20):6625-33. doi: 10.1158/1078-0432.CCR-08-0701.

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14.

引用本文的文献

Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer.

Transl Oncol. 2025 Jun;56:102387. doi: 10.1016/j.tranon.2025.102387. Epub 2025 Apr 14.

Breast acinic cell carcinoma with weak progesterone receptor expression: a case report and literature review.

Front Oncol. 2025 Feb 20;14:1497272. doi: 10.3389/fonc.2024.1497272. eCollection 2024.

Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ERPRHER2) breast cancer.

Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023.

Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.

Cancer Causes Control. 2024 Jun;35(6):921-933. doi: 10.1007/s10552-024-01856-6. Epub 2024 Feb 16.

Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy.

Diagn Pathol. 2024 Jan 4;19(1):5. doi: 10.1186/s13000-023-01433-6.

Visualized machine learning models combined with propensity score matching analysis in single PR-positive breast cancer prognosis: a multicenter population-based study.

Am J Cancer Res. 2023 Jun 15;13(6):2234-2253. eCollection 2023.

Single progesterone receptor-positive phenotype has the similar clinicopathological features and outcome as triple-negative subtype in metastatic breast cancer.

Front Oncol. 2023 Feb 24;13:1029648. doi: 10.3389/fonc.2023.1029648. eCollection 2023.

An update on the pathological classification of breast cancer.

Histopathology. 2023 Jan;82(1):5-16. doi: 10.1111/his.14786.

CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.

Cancers (Basel). 2022 Nov 6;14(21):5453. doi: 10.3390/cancers14215453.

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.

Breast J. 2022 May 17;2022:9238804. doi: 10.1155/2022/9238804. eCollection 2022.

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

作者信息

出版信息

相似文献

引用本文的文献